Here are seven highlights:
1. In 2015 the market was valued at $5.867 million.
2. The global spinal fusion devices market is driven by minimally invasive spine surgery techniques and rise in incidence of spinal disorders.
3. The thoracolumbar fusion devices segment accounted for more than 40 percent share of the global market and is expected to grow at a compound annual growth rate of 3.6 percent.
4. France and Germany accounted for nearly 40 percent shares of the European spinal fusion devices market in 2015.
5. North America accounted for the majority revenue share in 2015 and is expected to maintain this trend.
6. Improving healthcare infrastructure and an increase in expenditures in the emerging markets have bolstered the global market growth.
7. Major companies, including Alphatec Holdings, B. Braun Melsungen AG and DePuy Synthes, are focused on expanding their business operations in the fast-growing economies by adopting the product launch strategy.
More articles on devices and implants:
Amedica reports preliminary 2016 revenue of $15.2M – 10 highlights
Camber Spine Technologies fills 2 newly created sales director roles: 5 notes
Stryker, Life Spine, NuVasive & more: 7 device company key notes
